Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 2.495
+0.030 (1.22%)
Aug 1, 2025, 4:25 PM CET
Verve Therapeutics Market Cap
Thor Medical ASA has a market cap or net worth of 870.72 million as of August 1, 2025. Its market cap has increased by 259.24% in one year.
Market Cap
870.72M
Enterprise Value
748.07M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$2.50
Market Cap Chart
Since July 4, 2023, Thor Medical ASA's market cap has increased from 466.61M to 870.72M, an increase of 86.61%. That is a compound annual growth rate of 34.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 870.72M | 18.03% |
| Dec 30, 2024 | 737.69M | 144.87% |
| Dec 29, 2023 | 301.27M | -35.44% |
| Jul 4, 2023 | 466.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.18B |
| Nordhealth AS | 3.04B |
| Photocure ASA | 1.68B |
| Vistin Pharma ASA | 1.08B |
| Omda AS | 1.04B |
| ArcticZymes Technologies ASA | 939.71M |
| Gentian Diagnostics ASA | 913.00M |
| Lytix Biopharma AS | 607.53M |